S476-118

Introduced

To amend title XI of the Social Security Act to protect access to genetically targeted technologies.

118th Congress Introduced Feb 16, 2023

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill defines amendment to definition of qualifying single source drug Section 1192(e) of the Social Security Act (42 U.S.C. It relies on definition changes and product standards. The main policy areas are Healthcare, Science & Space, and Healthcare Consumers.

Who Benefits and How

Public beneficiaries or protected communities affected by the clause could face reduced risk.

Who Bears the Burden and How

Researchers and scientific institutions affected by the bill would take on compliance duties and Patients and health care consumers affected by the bill would take on compliance duties.

Key Provisions

  • Defines amendment to definition of qualifying single source drug Section 1192(e) of the Social Security Act (42 U.S.C.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

The bill defines amendment to definition of qualifying single source drug Section 1192(e) of the Social Security Act (42 U.S.C.

Key Policy Areas

Healthcare, Science & Space, Healthcare Consumers

Primary Purpose

The bill defines amendment to definition of qualifying single source drug Section 1192(e) of the Social Security Act (42 U.S.C.

Policy Domains

Healthcare Science & Space Healthcare Consumers

Whole bill

Identified Gains
  • Public beneficiaries or protected communities affected by the clause
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: is
Public beneficiaries or protected communities affected by the clause:
Identified Costs
  • Researchers and scientific institutions affected by the bill
  • Patients and health care consumers affected by the bill
Model: codex-gpt-5:bulk-repair | Version: bill_summary_v2 | Source: is
Patients and health care consumers affected by the bill:
Researchers and scientific institutions affected by the bill:

Legislative Progress

Introduced
Introduced Committee Passed
Feb 16, 2023

Mr. Menendez (for himself and Mrs. Blackburn) introduced the following …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Science & Space Healthcare Consumers

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology